Variant · Snv
IFIH1 NM_022168.4(IFIH1):c.1641+1G>C
CI-VAR-00047060Explore in graph →NM_022168.4:c.1641+1G>CClinVar 261563 rs35337543
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 261563 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7; Multisystem inflammatory syndrome in children; Susceptibility to severe COVID-19; Immunodeficiency 95; Uterine corpus endometrial carcinoma; Sarcoma; Ovarian serous cystadenocarcinoma; Hepatocellular carcinoma; Nonpapillary renal cell carcinoma; Lymphoma; Uterine carcinosarcoma; Acute myeloid leukemia; Malignant tumor of esophagus; Clear cell carcinoma of kidney; Familial pancreatic carcinoma; Malignant lymphoma, large B-cell, diffuse; Colon adenocarcinoma; Adrenocortical carcinoma, hereditary; Thymoma; Lung cancer; Cervical cancer; Thyroid cancer, nonmedullary, 1; Melanoma; Ovarian cancer; Cholangiocarcinoma | germline | 12 | Jun 01, 2026 | clinvar |